Figures last updated 21 Oct 2026, 11:00 PM IST · How we work · Report an error
At the upper price band of ₹693
From the offer document’s own listed-peer table
The Red Herring Prospectus does not disclose the Price Band or Offer Price, leaving corresponding P/E and EV/EBITDA valuation multiples for the company unfinalized. For Fiscal 2026, listed industry peers traded at an average P/E multiple of 67.81 times (ranging from 42.92 to 116.41 times) and an average EV/EBITDA of 33.10 times.
How the size of this issue compares with every IPO in our archive
At ₹1,450 Cr, Paras Healthcare is a larger issue than 79% of the 719 Mainboard IPOs in our archive that state an issue size (the median is ₹572 Cr).
Of 178 Mainboard IPOs in our archive with an issue of ₹1,000 Cr to ₹5,000 Cr (listed 2010 to date), 69% opened above the issue price and 26% below. The median opening gain was +6.75%, and the middle half ranged from −1.09% to +22.91%.
This describes how past issues opened, not what this IPO will do: one issue can land far outside the range, the opening price says nothing about what happens afterwards, and past results are not a forecast.
| ₹135.0 |
| ₹134.9 |
| ₹657.6 |
| 59.4x |
| 21.9% |
| ₹25,228.5 |
| Fortis Healthcare Limited (“FHL”)Financial statements · Consolidated | ₹13.8 | ₹13.8 | ₹131.1 | 55.4x | 11.1% | ₹9,127.84 |
| Global Health Limited (“GHL”)Financial statements · Consolidated | ₹20.7 | ₹20.7 | ₹147.1 | 64.5x | 15.2% | ₹4,410.3 |
| Jupiter Lifeline Hospitals Limited (“JLHL”)Financial statements · Consolidated | ₹5.9 | ₹5.9 | ₹47.1 | 42.9x | 13.4% | ₹1,499.79 |
| Krishna Institute of Medical Sciences Limited (“KIMS”)Financial statements · Consolidated | ₹6.0 | ₹6.0 | ₹56.2 | 116.4x | 11.0% | ₹3,904.6 |